According to the FDA, a limited number of unaffected blood tests are available if providers are unable to identify a better way forward. 

Early data suggest the new transcatheter tricuspid valve repair device could make a big impact on patient care, but additional research is still necessary. 

The group collaborated with two other medical societies, SCAI and CHSS, on the expert consensus document. 

Results from a first-in-human study suggest this new-look device could provide cardiologists and their care teams with another way to treat tricuspid regurgitation in high-risk patients.

Cardiovascular Associates of America, which calls Orlando home, has made increasing its presence in the Sunshine State a top priority in 2023.

Roberto Lang, MD, has been closely involved with the development of AI technology that helps inexperienced ultrasound users perform high-quality echo exams. "It is an unbelievable thing when you see it working," he said. 

Three cardiology societies have reached out to CMS with questions about how MACs are interpreting a policy related to shared decision-making. 

The randomized, double-blinded phase 3 study revealed gadopiclenol to be noninferior to gadobutrol for all qualitative visualization parameters as rated by all blinded readers involved in the trial.

Mark Zuckerberg’s Meta is offering the latest version of its large language AI model, Llama 2, for free and on an open-source basis.